Cloacal exstrophy (CE) and persistent cloaca (PC) (alternatively termed urorectal septum malformation sequence [URSMS]), represent two major cloacal defects (CDs).
; URSMS (partial) includes males whose cloacal cavity consists of colon or rectum and bladder with a single opening (Wheeler & Weaver, 2001) . Other defects involving the gastrointestinal, skeletal, spinal, and genitourinary systems are reported frequently in CE and PC/URSMS (Keppler-Noreuil, 2001; Martinez-Frias, Bermejo, Rodriguez-Pinilla, & Frias, 2001 ; Van der Putte, Spliet, & Nikkles, 2008) .
Reported prevalence estimates for CE historically ranged from 1/200,000-1/400,000 births (Hurwitz, Manzoni, Ransley, & Stephens, 1987; Martinez-Frias et al., 2001; Soper & Kilger, 1964) however, other reviews reported higher estimates ranging from 1/10,000-1/70,000 live births (Caton, Bloom, Druschel, & Kirby, 2007; Evans, Darvill, Trevenen, & Rockman-Greenberg, 1985; Feldkamp et al., 2011; Hayden, Chapman, & Stevenson, 1973; Keppler-Noreuil, 2001; Kubota, 2017; MartinezFrias et al., 2001; Peterson & Nelson, 1982) . These higher estimates may be due, in part, to improved ascertainment of CE in stillbirths or to prenatal misdiagnosis (Keppler-Noreuil, Gorton, Foo, Yankowitz, & Keegan, 2007) . PC/URSMS has an estimated prevalence of 1 in 35,000-50,000 based upon a small number of population-based studies (Cuschieri & EUROCAT Working Group, 2001; Gray & Skandalakis, 1972; Tennant et al., 2014) . The population-based study by Tennant et al. (2014) in England and Wales reported that most cases of PC/URSMS (partial) were diagnosed with additional structural defects, one in two with renal anomalies, and one in four with gastrointestinal, cardiovascular, or limb anomalies. Additionally, results of a survey of 244 university hospitals and children's hospitals in Japan (Kubota, 2017) , showed similar findings of associated defects among PC cases.
The etiology for both CE and PC/URSMS remains unknown.
Although there have been individual cases of CE with chromosome abnormalities, including trisomy 18 (Carey et al., 1978) , 9q24.1-qter deletion (Thauvin-Robinet et al., 2004) , 3q12.2-q13.2 deletion (Kosaki, 2005) , and 1p36.13 deletion (El-Hattab et al., 2010) , there has been no single, recurrent chromosome abnormality associated with CE.
Similarly for PC/URSMS, there has been no single, recurrent chromosome abnormality, but there have been isolated reports of chromosome rearrangements of 7p and 8q in patients with a syndrome (Miller, Kaufman, Reed, Bilenker, & Schinzel, 1979; Ramos, McDonaldMcFinn, Emanuel, & Zackai, 1992) .
Previous array-based molecular analysis, copy number variant (CNV) studies, and selected candidate gene analyses did not reveal any pathogenic alterations associated with CE or PC (Draaken et al., 2013; Jenkins et al., 2007; Ludwig et al., 2009; Reutter, Hoischen, et al., 2007; Reutter, Qi, et al., 2007; Reutter, Thauvin-Robinet, Boemers, Rosch, & Ludwig, 2006; Vlangos et al., 2011) . A recent CNV study of 17 females with PC identified seven patients with CNVs, two of which were novel, a de novo deletion on 1q32.1q32.3 and a paternally inherited duplication on 16p13.2 (Harrison, Seideman, & Baker, 2014) ; however, sequencing of candidate gene HHAT in these 17 patients was negative (Harrison et al., 2014) . Also, a mutation in Uroplakin IIIA (UPIIIA) identified in a patient with PC and renal dysplasia was not replicated in a subsequent study of 20 PC patients sequenced for mutations in the UPIIA, SHH, HNF1B, and EFNB2 genes (Jenkins et al., 2005 (Jenkins et al., , 2007 .
The one published whole exome sequencing study of CE, which was conducted in eight child-parent trios, identified variants in three genes-PRPF38A, PRPF8, and SLC20A1-by in silico prediction programs; however, only the SLC20A1 variant was considered plausible based upon its known expression pattern (Reutter et al., 2016) . Sanger sequencing of additional CE patients did not reveal any potentially causative variants in SCLC20A1 (Reutter, personal communication) . An unpublished whole exome sequencing study in six CE child-parent trios performed through the Center for Mendelian Genomics at the University of Washington did not reveal any plausible candidate genes (Keegan et al, unpublished) . Additionally, the few candidate gene and genome-wide association studies performed to date on the bladder exstrophy-epispadias complex (BEEC)-which includes BE, PC, and CE-reported several potential candidate genes, including ISL1 (Draaken et al., 2015) , p63 (Qi et al., 2013; Wilkins et al., 2012) , and WNT3 (Reutter et al., 2014) .
Most cases of CDs occur sporadically and empirical recurrence risk is low. A few reports of recurrence of CE, PC, or associated defects, such as anal atresia, bladder exstrophy, or omphalocele, in families were identified (Aggarwal & Phadke, 2013; Gambhir et al., 2008; Keppler-Noreuil, 2001; Mills & Pergament, 1997; Smith et al., 1992) with a higher reported occurrence in monozygotic twins (Koffler, Aase, Papile, & Coen, 1978; Kramer et al., 1997; Lee et al., 1999; Lubusky et al., 2006; McLaughlin, Marks, & Jones, 1984; Redman, Seibert, & Page, 1981; Schinzel, Smith, & Miller, 1979; Siebert, Rutledge, & Kapur, 2005; Smith et al., 1992) and concordant conjoined twins with CE (Goldfischer et al., 1997; Metneki & Czeizel, 1989; Tihtonen, Lagerstedt, Kahkonen, & Kirkinen, 2009 ) than in singletons. Despite the absence of consistent genetic reports, findings from monozygotic twin studies support a genetic etiology for CE and PC; however, reports of discordant dizygotic twins (Achiron, Frydman, Lipitz, & Zalel, 2000; Bruch, Adzick, Glodstein, & Harrison, 1996) cannot exclude environmental, epigenetic, or somatic mosaic etiologies.
Previous epidemiologic studies have reported clinical findings and possible risk factors for CE (Boyadjiev et al., 2004; Caton et al., 2007; Gambhir et al., 2008; Martinez-Frias et al., 2001) , although some of these studies did not analyze CE separately from PC or BE (Boyadjiev et al., 2004; Cuschieri & EUROCAT Working Group, 2001; Gambhir et al., 2008) . CE and BE may have different pathogeneses based upon their different clinical characteristics, prevalence, and demographics (Caton et al., 2007; Martinez-Frias et al., 2001) . With regard to CE, associations have been reported with low birth weight, preterm gestation, and twinning (Boyadjiev et al., 2004; Caton et al., 2007; Gambhir et al., 2008; Martinez-Frias et al., 2001) and, also, with maternal use of clomiphene citrate (Reefhuis et al. (2011) . Additionally, possible maternal exposures to diazepam and diphenylhydantoin was thought to be a risk factor in a single case report (Carey et al., 1978) .
With the limitations in case definitions used and paucity of risk factors examined in previous epidemiologic studies of CE and PC/ URSMS, we conducted a comprehensive clinical and risk factor analysis of CE and PC (inclusive of URSMS) (henceforth collectively termed cloacal defects [CDs] ) using data from the National Birth Defects Prevention Study (NBDPS), a multi-state population-based case-control study. Our study objectives using this systematically identified sample of CD cases were to describe clinical findings for cases, including occurrence and types of other major birth defects, and to examine associations between CDs and selected child and maternal characteristics, as well as maternal prepregnancy and periconceptional exposures.
| METHODS
The NBDPS examined risk factors for over 30 major birth defects; methodology for the study has been described previously (Reefhuis et al., 2015; Yoon et al., 2001) . Included in the current analyses were cases with one or more eligible defects and unaffected live born controls with estimated dates of deliveries (EDDs) 
| Case classification
Clinical information abstracted from medical records was reviewed by a clinical geneticist at each NBDPS site, and standard definitions were used to determine case classification (Rasmussen et al., 2003) . An expanded version of the British Paediatric Association (BPA) codes (themselves an expansion of the International Classification of Disease Coding Modification Version 9 [ICD-9-CM]) were used to code NBDPS-eligible defects.
The BPA code used for CDs, which included CE and PC, was 751.550.
Classification of all NBDPS cases with a CD was performed by two clinicians (KKN, JCC) to confirm diagnosis of CE or PC and assign each case as isolated or multiple (presence of other unassociated major birth defects). The case definition and diagnosis of an isolated or complex sequence CE case required the presence of BE or CE and imperforate anus with either omphalocele or spina bifida. Other associated defects with isolated CE may have included spinal, kidney/urinary tract, gastrointestinal, or ambiguous or incompletely formed genitalia. PC and URSMS were used synonymously in this study, recognizing that URSMS occurs in males and females, and that PC is used to describe these defects in females. For the purposes of describing our results, the term PC is used to represent the cases of PC and URSMS combined.
The case definition for isolated PC required a common cloacal cavity with bladder and intestinal elements (and vaginal elements in the females) invariably accompanied by an anorectal defect, usually imperforate anus, but without exstrophy. An isolated PC case may have included the same associated defects as described for isolated CE. A multiple CE or PC case was defined as the respective primary defect plus other unassociated defects (e.g., congenital heart defects, brain defects, limb defects, craniofacial defects, or lung hypoplasia). All cases of CE diagnosed by physical examination or autopsy were required to have at least an omphalocele, BE, and an anorectal defect. Cases described as probable or possible CE were excluded.
| Data collection
Clinical data collected through medical record abstraction included demographic data, prenatal history, and clinical findings with occurrence and types of presenting birth defects. Structured, computer-assisted telephone interviews were conducted with birth mothers of cases and controls; interviews were conducted from 6 weeks to 2 years following the EDD of the case or control. The maternal interview included, but was not limited to, detailed items about demographic characteristics, pregnancy history, pregnancy intention, use of fertility procedures, medical history, and maternal use of nutritional supplements, medications, tobacco, alcohol, and illicit drugs. For most items, information was collected for each of the three months before pregnancy (B3-B1), each month of the first trimester (M1-M3), and by trimester for the remainder of the pregnancy (T2 and T3). In our analysis, unless otherwise specified, exposures were coded for the periconceptional period (1 month before pregnancy [B1] through the third month of pregnancy [M3]).
| Statistical analysis
We analyzed child and maternal characteristics and maternal prepregnancy and periconceptional exposures. We compared child and maternal characteristics of controls with those for all CDs combined, CE only, and PC only; analyses were also stratified by isolated or multiple CE or PC phenotypes and compared to controls. Additionally, we compared child and maternal characteristics between CE and PC cases. Characteristics were compared using chi-square or Fisher's exact tests (when expected cell counts <5) to determine statistical differences (p < 0.05).
Child characteristics compared were sex (female, male), gestational age (<37 weeks, 37-45 weeks), plurality (singleton, multiple), and for CE versus PC cases only, birth outcome (live birth, stillbirth, elective termination). Maternal characteristics compared were age at delivery (<20 years, 20-34 years, ≥35 years), race and ethnicity (nonHispanic White, non-Hispanic Black, Hispanic, other), education at delivery (<12 years, 12 years, ≥13 years), study site (AR, CA, CDC/GA, IA, MA, NC, NJ, NY, TX, UT), gravidity (first pregnancy, second pregnancy, third or higher pregnancy), previous miscarriage (yes, no), and planned pregnancy (yes, no, did not care).
Maternal prepregnancy exposures examined were use of fertility medication or assisted reproductive technology (ART) procedure, antagonists, but no case or control mother reported use of these medications. The retinoic acid medication examined was Retin-A.
Crude odds ratios (cORs), adjusted odds ratios (aORs), and 95%
confidence intervals (CIs) were estimated using logistic regression analysis to investigate the associations of any CD, CE, and PC with maternal prepregnancy and periconceptional exposures. Adjusted analyses were conducted only for levels of exposures that included at least five exposed case mothers. Exact logistic regression was used for crude and adjusted analyses of the association of a case group with an exposure when at least one level of exposure included fewer than five case mothers. Covariables examined were child sex and plurality, along with maternal age at delivery, race and ethnicity, education at delivery, and study site. Each covariable was added separately to the exposureonly model; covariables that changed the cOR estimate by more than 10% were included in the adjusted model for the respective case group and exposure. No restrictions were placed on the number of covariables that could be included in the adjusted models. Because the focus of our paper was to explore potential exposures for CE and PC singly, we chose not to include an exposure as a covariable in model testing of other exposures. Instead, selected covariables from previous studies of CDs and that preceded the critical fetal developmental period, along with NBDPS study site, were evaluated for inclusion in adjusted analyses. All analyses were conducted using the Statistical Analysis System (SAS) version 9.3 statistical software (SAS institute, Cary, NC).
| RESULTS
Clinical and maternal interview data were available for 101 children with CDs and 11,829 control children. Overall, participation in the maternal interview was 67% among case mothers and 64% among control mothers. The median time between EDD and interview date was 11 months for case mothers and 7 months for control mothers.
Of the 101 CD cases, 47 were classified with CE (Isolated = 33; Multiple = 14) and 54 with PC (Isolated = 26; Multiple = 28) ( Table 1) .
Findings of limb body wall complex (LBWC) were observed for two isolated CE cases, including one with short umbilical cord, and one possible LBWC was observed among isolated PC cases. Among the cases classified as multiple CE, congenital heart defects were most commonly observed followed by limb deficiency defects, specifically tibial agenesis. Among multiple PC cases, congenital heart defects and phenotypes that resembled those in VACTERL (vertebral defects, anal atresia, cardiac defects, tracheo-esophageal fistula, renal anomalies, and radial limb abnormalities) association were observed most often. 
| Child and maternal characteristics
Comparing child characteristics between each case group (any CD, CE, PC) and controls, we observed a female excess for any CD case, accounted for largely by PC (Table 2) . Children in each case group were statistically more likely (p < 0.05) to be preterm, and those with any CD and CE were more likely to be from a multiple pregnancy than controls.
Differences observed for isolated and multiple CE cases and for isolated and multiple PC cases were similar to those observed for all CE and all PC cases, respectively (data not shown). Comparing CE and PC cases, we observed that PC cases were statistically less likely to be preterm or a multiple pregnancy than CE cases; no statistical difference was observed among birth outcomes between CE and PC cases (data not shown).
Comparing maternal demographic and reproductive history characteristics between each case group and controls, we observed no statistical differences (Table 2) . Likewise, comparison of these characteristics did not produce statistical differences between CE and PC cases. No case mother reported a diagnosis of diabetes prior to pregnancy.
| Maternal prepregnancy and periconceptional exposures
Outcome and exposure model-specific covariables identified for inclusion in adjusted analyses are shown in Table 3 . Results of crude analysis are presented in Table 4 ; results of adjusted analysis 
We observed that CDs grouped as CE or PC had similar and overlapping kidney, urinary, GI, and skeletal/spinal defects. The most frequently associated defects with both multiple CE and PC were congenital heart defects. CE has overlapping findings with LBWC, including its association with limb deficiency defects, whereas PC more often had overlapping findings with VACTERL association. This overlap between CE, PC, LBWC, and VACTERL association was reported previously and may suggest that these conditions represent a spectrum and share a common pathogenetic mechanism (Bohring, 2002; Curry, Boyd, & Stevenson, 2006; Feldkamp et al., 2011; Heyroth-Griffis, Weaver, Faught, Bellus, & Torres-Martinez, 2007; Keppler-Noreuil et al., 2007) ; however, CE and PC do have distinguishing characteristics. In particular, isolated CE occurred more frequently compared to isolated PC, which was more likely to have other multiple, unassociated defects. Kubota (2017) and Tennant et al. (2014) also observed in their descriptive population-based study that most cases of PC had additional structural birth defects, including renal (in one-half of cases), digestive, system, cardiovascular, or limb anomalies (in one-quarter of cases).
For all CDs, we observed an excess of females, attributed to PC cases. There were almost equal counts of females (22) and males (21) with CE, whereas there were 49 females and 4 males included under the PC designation. These results are similar to other studies of CE and PC (Caton et al., 2007; Feldkamp et al., 2011; Kubota, 2017; MartinezFrias et al., 2001) . In this study, PC was considered inclusive of URSMS, as have other researchers studying these malformations (Cuschieri & EUROCAT Working Group, 2001; Tennant et al., 2014; Wheeler & Weaver, 2001 ). In addition, the NBDPS study used the ICD-9 Clinical
Modification coding scheme, and there is only a code for PC (not URSMS); however, the CDs described under this code include the URSMS. Urorectal septum malformation sequence may occur in both males and females as documented by Wheeler & Weaver (2001) ; when it occurs in females, these malformations are often referred to as PC (Peña, 2016) . We observed that preterm birth was positively associated with CE and PC compared to controls, and higher among CE cases compared to cases with PC. Associations between preterm birth and CE were described in two previous studies (Caton et al., 2007; Martinez-Frias et al., 2001) . We also observed that plurality was significantly associated with CE, but not PC. Among the different hypotheses of CE pathogenesis, the association with plurality may support two particular hypotheses. One hypothesis being that both CE and twinning may be manifestations of the same early disturbance of morphogenesis, occurring as early as blastogenesis (McLaughlin et al., 1984; Schinzel et al., 1979) . The second hypothesis being that partial or complete duplication of the organizing center within a single embryonic disc may increase the risk of mesodermal insufficiency, accounting for failure of cloacal membrane development leading to exstrophy (Siebert et al., 2005) . Sadler and Feldkamp (2008) also proposed that disruption of the embryonic disc and failure of migration of the lateral body wall folds to meet at the midline could lead to ventral body wall defects. During later stages of gastrulation, the caudal eminence functions as a developmental field that is modulated by homeobox genes and a variety of other factors. Histopathologic studies in human embryos also support that CE is likely the result of a very early defect of insufficient cellular proliferation or deposition involving the caudal eminence (Feldkamp et al., 2011; Hartwig, Steffelaar, Van de Kaa, Schueler, & VermeijKeers, 1991; Nievelstein, van der Werff, Verbeek, Valk, & VermeijKeers, 1998; Van der Putte et al., 2008) .
Our analysis of selected maternal characteristics and exposures was based in part upon previous anecdotal reports and known risk factors for component or related birth defects (e.g., caudal dysgenesis, neural tube defects, sacral agenesis with maternal diabetes) (Chappell, Wang, & Loeken, 2009; Dheen et al., 2009; Yazdy et al., 2010; Zhu, Kartiko, & Finnell, 2009) , and folate deficiency (Czeizel & Dudas, 1992) . The positive associations observed for use of any fertility medication or an ART procedure with any CD, CE, and PC were statistically significant in crude and adjusted analyses. An increased risk for anorectal malformations and exstrophy-epispadias complex in children born after ART with both in-vitro fertilization and intracystoplasmic sperm injection was reported in two German case-control studies (Zwink et al., 2012 (Zwink et al., , 2013 . In an earlier analysis using NBDPS data through 2005, Significant positive associations observed in crude analysis for reports of maternal obesity (with any CD) and any x-ray (with any CD and CE) had no covariables meet the criteria for inclusion in an adjusted model. Risk of birth defects (including defects of the heart, central nervous system defects, limbs, urinary tract, and genital systems) in offspring of mothers who were in overweight and obesity categories were observed to be higher than background risk of major malformations in the general population (Persson et al., 2017; Stothard, Tennant, Bell, & Rankin, 2009; Tang et al., 2015) . Our study supports these findings, and adds CDs as specific anorectal and genital defects that show a positive association with maternal obesity. Further, we observed associations with any CD and CE with any maternal x-ray exposure. Exposure to x-rays as a risk factor for any CD specifically has not been previously reported. The risks of teratogenic effects from xrays (ionizing radiation) vary based upon the radiation dose and the stage of development of the embryo/fetus, with the greatest susceptibility during organogenesis (2-7 weeks after conception) and in the early fetal period (8-15 weeks after conception) (Streffer et al., 2003; Williams & Fletcher, 2010) . These are also the critical periods when development from the cloaca to the urinary, genital, and lower gastrointestinal tract are occurring. These associations provide some of the first insights into differing risk for CE and PC with several maternal Examination of a large number of characteristics and exposures was also a potential limitation. Because of the rather limited literature on risk factors for CDs, our study was intended to be a hypothesis-generating study, so we did not adjust for multiple comparisons. Relatedly, because of the rather modest number of exposed cases for some risk factors, we examined each risk factor independently rather than as combinations of risk factors. Our analyses were also based on retrospective self-reports of exposures, which may have introduced recall bias between case and control mothers. Additionally, nearly one-third of mothers contacted declined to be interviewed raising concerns about the generalizability of our findings, and bias may have been introduced due to unmeasured differences between maternal participants and non-participants;
however, control mothers participating in the NBDPS have been reported to be generally representative of the underlying population from which they were selected (Cogswell et al., 2009 ).
The involvement of structures in the caudal developmental field and the likely differences in embryologic timing of these CDs suggest there may be disruption of spatiotemporal gene expression in separate genes in the same pathway. There are other groups of conditions with similar overlapping features caused by mutations in signaling pathway genes, for example in the disorders of the RAS-MAPK (Rasopathies) and the PI3K-AKT pathways. We hypothesize that CE with its features, including its sporadic occurrence, predominantly isolated presentation, and the caudal distribution of its composite defects, is caused in large part by an early somatic mutation. Potential candidate genes may include one of the homeobox genes, such as HLXb9, p63, or SHH-WNT-PTC1-GL1 signaling genes. These genes have not been identified to date, because previous genetic studies used blood specimens to examine germline mutations. The expression of these somatic mutations also may be modified by other mutations or environmental risk factors.
Based upon this hypothesis, our future studies will include evaluating affected tissue from individuals with CE for somatic mosaicism.
In summary, our clinical and risk factor analysis identified statistically significant positive associations with reported maternal use of any fertility medication or an ART procedure, pre-pregnancy obesity, and periconceptional exposure to x-rays. We observed that although there is overlap in the clinical and epidemiologic findings of CE and PC, there are distinct differences, which suggest that these conditions may have different etiologies. Both our clinical findings and positive associations with maternal exposures suggest possible hypotheses for etiology and pathogenesis of CDs. Further investigations of the role of genetic, including somatic mutations, and potential interacting environmental risk factors for CDs, and in particular CE, are needed to understand the underlying cause(s) of these defects.
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